Imactiv-3D: Evaluation by imaging of the molecular activity in pre-clinical phases

17 March 2017

A MODULAR AND FULLY CUSTOMIZABLE SERVICE FOR THE 3D QUANTITATIVE EVALUATION OF THE ACTIVITY OF YOUR COMPOUNDS

The leitmotif of the Imactiv-3D company is to meet the challenges of evaluation of active molecules:

• Understanding the mechanisms of action of molecules of interest
• Assess their activity at the pre-clinical phase in predictive biological 3D models
• Reduce the risk of failure of candidate molecules at the clinical stage

Imactiv-3D supports pharmas and biotech companies in their development strategy, study or research on innovative and reliable predictive models to help them in their decision making.

Imactiv-3D relies for this on three complementary expertise:
• In the use of commercially available 3D models, the management of your own models or samples, or the development of custom innovative 3D models,
• In the exploitation of 3D models and tissue imaging equipments at the forefront of technology, for the visualization and artwork of your samples (3D Models, tissues, organs)
• In the development of 3D image characterization methods to yield the objective and quantitative assessment of the effectiveness of compounds in preclinical phase.

Read more…

Tél : +33 5 82 99 10 09

1 Place Pierre Potier

31100 TOULOUSE


Save time and easily find the methods and the testing suppliers to substantiate your actives and cosmetics claims.

Don't miss our weekly newsletter

* Receive regular news of what's moving the world of preclinical and clinical testing of the Beauty industry

Save time and easily find the methods and test providers to validate your product claims.